MHC/HLA and Disease Association
Definition
The major histocompatibility complex (MHC) is a group of genes on the short arm of chromosome 6. In humans it is called the human leukocyte antigen (HLA) complex.
Its main function is to present antigenic peptides to T lymphocytes. Because HLA genes are highly polymorphic, certain alleles can predispose individuals to particular immune-mediated diseases.
- Class I HLA: HLA-A, HLA-B, HLA-C
- Present endogenous or cytosolic antigens to CD8+ T cells
- Present on all nucleated cells
- Class II HLA: HLA-DP, HLA-DQ, HLA-DR
- Present extracellularly derived antigens to CD4+ T cells
- Mainly on antigen-presenting cells
Robbins & Kumar Basic Pathology, pp. 159-160.
Basis of HLA-Disease Association
Most autoimmune diseases are multifactorial and polygenic. HLA alleles are susceptibility genes, not direct causes of disease.
A disease-associated HLA molecule may predispose to autoimmunity by:
- Presenting self-peptides efficiently to autoreactive T cells.
- Failing to eliminate autoreactive T cells during thymic selection.
- Altering immune responses to environmental triggers, especially infections.
- Being inherited in linkage disequilibrium with another nearby susceptibility gene.
Important point
- The presence of an HLA allele does not mean the person will develop disease.
- Similarly, a person may develop the disease even without that allele.
- Thus, HLA association indicates increased relative risk, not diagnostic certainty.
For example, HLA-DR4 increases the risk of rheumatoid arthritis about 3-4 fold, whereas HLA-B27 has a very strong association with ankylosing spondylitis, with a relative risk of 100 or more. Robbins & Kumar Basic Pathology, p. 177.
Important HLA-Disease Associations
| Disease | Associated HLA allele/haplotype |
|---|
| Ankylosing spondylitis | HLA-B27 |
| Reactive arthritis | HLA-B27 |
| Acute anterior uveitis associated with spondyloarthropathy | HLA-B27 |
| Rheumatoid arthritis, especially ACPA-positive RA | HLA-DR4 |
| Type 1 diabetes mellitus | HLA-DR3, HLA-DR4; HLA-DQ2/DQ8 |
| Systemic lupus erythematosus | HLA-DR2, HLA-DR3 |
| Multiple sclerosis | HLA-DR2 |
| Celiac disease | HLA-DQ2, HLA-DQ8 |
| Graves disease | HLA-DR3 |
| Hashimoto thyroiditis | HLA-DR5 |
| Myasthenia gravis | HLA-DR3 |
| Goodpasture syndrome | HLA-DR2 |
| Pemphigus vulgaris | HLA-DR4 |
| Psoriasis | HLA-Cw6 |
| Behçet disease | HLA-B51 |
| Narcolepsy | HLA-DQ6 |
Clinical Significance
- Disease susceptibility: HLA typing can indicate genetic predisposition, particularly in ankylosing spondylitis and celiac disease.
- Diagnosis support: HLA-B27 supports, but does not establish, a diagnosis of ankylosing spondylitis.
- Exclusion value: Absence of HLA-DQ2/DQ8 makes celiac disease very unlikely.
- Transplantation: HLA matching reduces graft rejection.
- Drug hypersensitivity: Certain HLA alleles predict severe adverse reactions, for example HLA-B*57:01 with abacavir hypersensitivity.
Conclusion
HLA genes influence the nature of antigen presentation and T-cell responses. Their polymorphism explains susceptibility to several autoimmune and inflammatory diseases. However, HLA alleles confer risk only; development of disease also requires other genetic and environmental factors such as infection, inflammation, and breakdown of self-tolerance.
Exam one-liner:
HLA-disease association refers to increased susceptibility to particular autoimmune diseases in individuals carrying specific MHC alleles; the strongest classic association is HLA-B27 with ankylosing spondylitis.